Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
Myxomatous mitral valve disease (MMVD) is characterized by thickening of the valve leaflets and omega-3 (ω-3) supplementation has been associated with modulation of blood pressure (BP) and heart rate, improvement of doppler echocardiographic indices, antiarrhythmic, anti-inflammatory and anti-dislip...
Guardado en:
Autores principales: | Priscilla Regina Nasciutti, Aline Tavares Moraes, Thaiz Krawczyk Santos, Karine Kelly Gonçalves Queiroz, Ana Paula Araújo Costa, Andressa Rodrigues Amaral, Rodrigo Fernando Gomes Olivindo, Cristiana Ferreira Fonseca Pontieri, Juliana Toloi Jeremias, Thiago Henrique Annibale Vendramini, Marcio Antonio Brunetto, Rosângela de Oliveira Alves Carvalho |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da6e03ea3fc0404a985a4faa9bcbaa3e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
por: R. Araki, et al.
Publicado: (2021) -
Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease
por: Julio P. dos Santos, et al.
Publicado: (2021) -
The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs
por: Tommaso Vezzosi, et al.
Publicado: (2021) -
Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease
por: Qinghong Li, et al.
Publicado: (2021) -
Retrospective evaluation of notched and fragmented QRS complex in dogs with naturally occurring myxomatous mitral valve disease
por: Radu Andrei Baisan, et al.
Publicado: (2021)